<DOC>
	<DOCNO>NCT02389218</DOCNO>
	<brief_summary>Prospective trial compare efficacy safety CryoBalloonAblation ( CBA ) standardize medication treatment early onset persistent atrial fibrillation ( AF ) without structural heart disease . The value CBA patient never study ; endpoint persistent patient much easy paroxysmal patient . Reduction leave atrial ( LA ) size compare versus patient drug therapy versus fail patient .</brief_summary>
	<brief_title>A Prospective Study Medical Therapy Against Cryoballoon Ablation Symptomatic Recent Onset Persistent AF</brief_title>
	<detailed_description>The total AF history shorter 24 month . Symptomatic patient include within last year least 2 episode document AF , last minimal 30 sec . One episode entire history last 48 h , require electrical pharmacological cardioversion stop spontaneously 7 day . All patient eligible study sign inform consent , echocardiogram prior inclusion exclude severe leave ventricular dysfunction , rule significant valve abnormality , leave ventricular hypertrophy ass LA volume diameter . Prior randomization , inclusion suggest local investigator perform MRI-scan CT scan LA pulmonary vein ( branch study ) eligible patient assess anatomy leave atrial volume . The result influence strategy treatment .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<mesh_term>Propafenone</mesh_term>
	<criteria>&gt; 21 year legally capable First documentation history symptomatic AF 30 sec within last 2 year Twice AF within last year One episode cardioverted 48 hour spontaneously terminate 7 day Eligible least one first step drug therapy ( sotalol , propafenone , flecainide ) amiodarone Left ventricular ejection fraction estimate &gt; 45 % LA diameter &lt; 50 mm ( parasternal short axis ) LA volume le 100 ml ( apical view , Area Length method ; ) CHADS2 â‰¤ 2 Failed AAD strategy , untreated AAD No use Amiodarone previous 3 month ( except IV oral 7 day ) Informed consent Age &gt; 75 yr CHF Ischemic heart disease know history ( Severe ) Left ventricular hypertrophy show echo ( IVSd PWd &gt; 14 mm ) Hyperthyroidism Congenital heart disease Hypertrophic Cardiomyopathy , Arrhythmogenic Right ventricular Cardiomyopathy , channelopathies Contraindications AAD Long QT syndrome Received already adequately dosed level 1 drug ( sotalol , propafenone , flecainide ) Pure ( typical ) atrial flutter document one occasion</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>cryoablation</keyword>
	<keyword>catheter ablation</keyword>
</DOC>